![](/img/cover-not-exists.png)
Cost-Effectiveness of Nivolumab + Ipilimumab in First-Line Treatment of Advanced Melanoma
Baker, TM, Paly, VF, Sabater, J, Okoro, T, Kotapati, S, Briggs, AVolume:
19
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2016.09.2198
Date:
November, 2016
File:
PDF, 70 KB
english, 2016